136 related articles for article (PubMed ID: 36622840)
1. Interactions of Apolipoproteins with Lipid-Based Nanoparticles.
Dalhaimer P; Florey B; Isaac S
ACS Nano; 2023 Jan; ():. PubMed ID: 36622840
[TBL] [Abstract][Full Text] [Related]
2. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes.
Fleischer CC; Payne CK
Acc Chem Res; 2014 Aug; 47(8):2651-9. PubMed ID: 25014679
[TBL] [Abstract][Full Text] [Related]
4. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
[TBL] [Abstract][Full Text] [Related]
5. Coronal ApoE Protein Combines with LRP1 to Inactivate GSK3β That Mitigates Silica Nanoparticle-Induced Brain Lesion.
Wei W; Sun H; Yang B; Song E; Song Y
ACS Chem Neurosci; 2024 Feb; 15(4):808-815. PubMed ID: 38315060
[TBL] [Abstract][Full Text] [Related]
6. Size Dependence Unveiling the Adsorption Interaction of High-Density Lipoprotein Particles with PEGylated Gold Nanoparticles in Biomolecular Corona Formation.
Jang GJ; Jeong JY; Kang J; Cho W; Han SY
Langmuir; 2021 Aug; 37(32):9755-9763. PubMed ID: 34347501
[TBL] [Abstract][Full Text] [Related]
7. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
[TBL] [Abstract][Full Text] [Related]
8. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
[TBL] [Abstract][Full Text] [Related]
10. Binding of apolipoprotein A-I and A-II after recombination with phospholipid vesicles to the high density lipoprotein receptor of luteinized rat ovary.
Hwang J; Menon KM
J Biol Chem; 1985 May; 260(9):5660-8. PubMed ID: 2985608
[TBL] [Abstract][Full Text] [Related]
11. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
[TBL] [Abstract][Full Text] [Related]
12. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
Barrán-Berdón AL; Pozzi D; Caracciolo G; Capriotti AL; Caruso G; Cavaliere C; Riccioli A; Palchetti S; Laganà A
Langmuir; 2013 May; 29(21):6485-94. PubMed ID: 23631648
[TBL] [Abstract][Full Text] [Related]
13. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
14. Plasma Parameters During Nanoparticle-Enhanced Laser-Induced Breakdown Spectroscopy (NELIBS) in the Presence of Nanoparticle-Protein Conjugates.
Dell'Aglio M; Mallardi A; Gaudiuso R; Giacomo A
Appl Spectrosc; 2023 Nov; 77(11):1253-1263. PubMed ID: 37700694
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
16. Impact of Nanoparticle Physicochemical Properties on Protein Corona and Macrophage Polarization.
Xiao B; Liu Y; Chandrasiri I; Overby C; Benoit DSW
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916683
[TBL] [Abstract][Full Text] [Related]
17. Electrokinetic elucidation of the interactions between persistent luminescent nanoprobes and the binary apolipoprotein-E/albumin protein system.
Ramírez García G; d'Orlyé F; Richard C; Mignet N; Varenne A
Analyst; 2021 Sep; 146(17):5245-5254. PubMed ID: 34296726
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipoproteins: apolipoprotein structure and function.
Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
J Lipid Res; 1984 Dec; 25(12):1277-94. PubMed ID: 6099394
[TBL] [Abstract][Full Text] [Related]
19. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
[TBL] [Abstract][Full Text] [Related]
20. PEGylated nanoparticles interact with macrophages independently of immune response factors and trigger a non-phagocytic, low-inflammatory response.
Asoudeh M; Nguyen N; Raith M; Denman DS; Anozie UC; Mokhtarnejad M; Khomami B; Skotty KM; Isaac S; Gebhart T; Vaigneur L; Gelgie A; Dego OK; Freeman T; Beever J; Dalhaimer P
J Control Release; 2024 Feb; 366():282-296. PubMed ID: 38123071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
